UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036997
Receipt number R000042153
Scientific Title Expansion of false lumen lead to rapid aortic enlargement in Stanford Type B aortic dissection
Date of disclosure of the study information 2019/06/07
Last modified on 2022/04/28 17:22:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Expansion of false lumen lead to rapid aortic enlargement in Stanford Type B aortic dissection

Acronym

The impact of false lumen expansion in type B aortic dissection

Scientific Title

Expansion of false lumen lead to rapid aortic enlargement in Stanford Type B aortic dissection

Scientific Title:Acronym

The impact of false lumen expansion in type B aortic dissection

Region

Asia(except Japan)


Condition

Condition

Stanford type B acute aortic dissection

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of study is to evaluate the impact of the false lumen diameter > the true lumen diameter.

Basic objectives2

Others

Basic objectives -Others

We investigate to detect the risk factor of late aortic events for patients with uncomplicated Type B aortic dissection

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

death from aortic events,surgery for dissected aorta, indication of surgery

Key secondary outcomes

The expansion rate of dissected aorta, especially in first 6 months after onset.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Uncomplicated stanford type B acute aortic dissection

Key exclusion criteria

non-acute case, complicated case

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Akihito
Middle name
Last name Matsushita

Organization

Seikeikai Chiba Medical Center

Division name

Cardiovascular surgery

Zip code

260-0842

Address

1-7-1, minami-cho, chuo-ku, chiba

TEL

043-261-5111

Email

akihito_matsu@yahoo.co.jp


Public contact

Name of contact person

1st name Akihito
Middle name
Last name Matsushita

Organization

Seikeikai Chiba Medical Center

Division name

Cardiovascular surgery

Zip code

260-0842

Address

1-7-1, minami-cho, chuo-ku, chiba

TEL

043-261-5111

Homepage URL


Email

akihito_matsu@yahoo.co.jp


Sponsor or person

Institute

Seikeikai Chiba Medical Center
Cardiovascular surgery

Institute

Department

Personal name



Funding Source

Organization

Seikeikai Chiba Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Seikeikai Chiba Medical Center

Address

1-7-1, minami-cho, chuo-ku, chiba

Tel

043-261-5111

Email

matsushita@seikeikai-cmc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 07 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

216

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

We are going to do follow up research.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 05 Month 10 Day

Date of IRB

2019 Year 05 Month 30 Day

Anticipated trial start date

2019 Year 06 Month 01 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry

2020 Year 03 Month 31 Day

Date trial data considered complete

2020 Year 03 Month 31 Day

Date analysis concluded

2020 Year 05 Month 31 Day


Other

Other related information

The study was finished. We wrote an article.


Management information

Registered date

2019 Year 06 Month 07 Day

Last modified on

2022 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042153